Ratings by BofA Securities (Tazeen Ahmad)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/16/2021 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
5/18/2021 Rhythm Pharmaceuticals RYTM Maintain Neutral
(N/A)
 
 
  Details
4/19/2021 BioNTech BNTX Maintain Neutral
(N/A)
 
 
  Details
3/10/2021 Acadia Pharmaceuticals ACAD Downgrade Neutral
(Buy)
25.02
(25.01)
-0.04% Details
3/9/2021 Incyte INCY Maintain Buy
(N/A)
 
 
  Details
2/12/2021 PTC Therapeutics PTCT Downgrade Neutral
(Buy)
63.27
(44.14)
-30.24% Details
2/12/2021 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
2/12/2021 Amicus Therapeutics FOLD Maintain Buy
(N/A)
 
 
  Details
1/27/2021 Rhythm Pharmaceuticals RYTM Maintain Neutral
(N/A)
 
 
  Details
1/13/2021 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
12/18/2020 Amicus Therapeutics FOLD Maintain Buy
(N/A)
 
 
  Details
12/1/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
12/1/2020 BioNTech BNTX Downgrade Neutral
(Buy)
109.99
(227.79)
107.1% Details
11/24/2020 SQZ Biotechnologies SQZ New Coverage Buy
(N/A)
27.62
(14.09)
-48.99% Details
11/20/2020 Prelude Therapeutics PRLD Downgrade Neutral
(Buy)
54.95
(32.97)
-40% Details
11/12/2020 Ultragenyx Pharma RARE Downgrade Neutral
(Buy)
117.48
(93.20)
-20.67% Details
11/10/2020 BioNTech BNTX Maintain Buy
(N/A)
 
 
  Details
10/27/2020 Galera Therapeutics GRTX Maintain Buy
(N/A)
 
 
  Details
10/20/2020 Prelude Therapeutics PRLD New Coverage Buy
(N/A)
32.69
(32.97)
0.86% Details
10/15/2020 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
10/15/2020 Incyte INCY Maintain Buy
(N/A)
 
 
  Details
10/15/2020 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
10/7/2020 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
9/14/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
8/21/2020 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
8/20/2020 BioNTech BNTX Maintain Buy
(N/A)
 
 
  Details
8/7/2020 Zogenix, Inc. ZGNX Maintain Buy
(N/A)
 
 
  Details
7/1/2020 Immunomedics IMMU Maintain Buy
(N/A)
 
 
  Details
6/24/2020 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
6/11/2020 Kala Pharmaceuticals KALA Maintain Buy
(N/A)
 
 
  Details
6/10/2020 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
5/27/2020 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
5/27/2020 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
5/12/2020 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
5/8/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
4/8/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
4/7/2020 Incyte INCY Maintain Buy
(N/A)
 
 
  Details
2/26/2020 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
2/18/2020 BioNTech BNTX Maintain Buy
(N/A)
 
 
  Details
2/18/2020 Cortexyme Inc. CRTX Maintain Neutral
(N/A)
 
 
  Details
2/18/2020 Kala Pharmaceuticals KALA Maintain Neutral
(N/A)
 
 
  Details
2/18/2020 Galera Therapeutics GRTX Maintain Buy
(N/A)
 
 
  Details
2/18/2020 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
2/18/2020 89bio Inc. ETNB Maintain Neutral
(N/A)
 
 
  Details
2/18/2020 MyoKardia MYOK Maintain Buy
(N/A)
 
 
  Details
1/23/2020 Clovis Oncology CLVS Maintain Neutral
(N/A)
 
 
  Details
1/23/2020 Fulcrrum Therapeutics FULC Maintain Buy
(N/A)
 
 
  Details
1/23/2020 Principia Biopharma PRNB Maintain Buy
(N/A)
 
 
  Details
1/14/2020 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
1/14/2020 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
1/14/2020 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
1/14/2020 PTC Therapeutics PTCT Maintain Buy
(N/A)
 
 
  Details
1/7/2020 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
1/7/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
12/9/2019 89bio Inc. ETNB New Coverage Neutral
(N/A)
28.60
(21.13)
-26.12% Details
11/26/2019 Acadia Pharmaceuticals ACAD Maintain Buy
(N/A)
 
 
  Details
11/21/2019 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
11/13/2019 Alnylam Pharmaceuticals ALNY New Coverage Buy
(N/A)
90.85
(173.68)
91.17% Details
8/26/2019 The Medicines Company MDCO Maintain Buy
(N/A)
 
 
  Details
8/20/2019 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
7/15/2019 Prevail Therapeutics PRVL New Coverage Buy
(N/A)
12.13
(23.00)
89.61% Details
6/21/2019 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
5/13/2019 PTC Therapeutics PTCT Upgrade Buy
(Neutral)
40.53
(63.27)
56.11% Details
5/7/2019 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
12/20/2018 DBV Technologies S.A DBVT Downgrade Underperform
(Buy)
14.15
(5.73)
-59.51% Details
11/28/2018 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
11/12/2018 Tesaro TSRO Maintain Neutral
(N/A)
 
 
  Details
10/26/2018 Seattle Genetics SGEN Downgrade Underperform
(Neutral)
65.35
(117.08)
79.16% Details
10/9/2018 Principia Biopharma PRNB Upgrade Buy
(N/A)
26.37
(100.05)
279.41% Details
10/5/2018 Adamas Pharmaceuticals ADMS Downgrade Neutral
(Buy)
19.98
(6.67)
-66.62% Details
10/3/2018 PTC Therapeutics PTCT Upgrade Neutral
(Underperform)
45.28
(40.53)
-10.49% Details
9/28/2018 GW Pharma GWPH Maintain Buy
(Buy)
 
 
  Details
9/21/2018 Acadia Pharmaceuticals ACAD Maintain Buy
(N/A)
 
 
  Details
9/14/2018 Zogenix, Inc. ZGNX New Coverage Buy
(N/A)
48.25
(17.99)
-62.72% Details
9/14/2018 Sarepta Therapeutics SRPT New Coverage Buy
(N/A)
150.77
(79.68)
-47.15% Details